PalonidipineAlternative Names: TC 81
Latest Information Update: 22 May 1995
At a glance
- Originator Teijin Pharma
- Class Antihypertensives
- Mechanism of Action Calcium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Angina pectoris; Hypertension
Most Recent Events
- 22 May 1995 Discontinued-preregistration for Angina pectoris in Japan (PO)
- 29 Mar 1995 Discontinued-preregistration for Hypertension in Japan (PO)